REFERENCES
- Botkin, J. R. 1995. Fetal privacy and confidentiality. Hastings Center Report 25 (5):32–39.
- Chen, S. C., and D. T. Wasserman. 2017. A framework for unrestricted prenatal whole-genome sequencing: Respecting and enhancing the autonomy of prospective parents. American Journal of Bioethics 17(1): 3–18.
- Cooper, D. N, P. C Krawczak, C. Polychronakos, et al. 2013. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Human Genetics 132 (10):1077–30.
- de Graaf, G, F. Buckley, and B. G. Skotko. 2015. Estimates of the live births, natural losses, and elective terminations of Down syndrome in the United States. American Journal of Medical Genetics A 167A (4):756–67.
- Mai, C. T., J. E. Kucik, J. Isenburg, et al. 2013. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006–2010: Featuring trisomy conditions. Birth Defects Research (Part A) 97:709–25.
- Rose, N. C., and B. Mercer. 2016. Screening for fetal aneuploidy. Practice bulletin #163. American College of Obstetricians and Gynecologists. Obstetrics & Gynecology 127 (5):979–81.
- Tasan, I., S. Jain, and H. Zhao. 2016. Use of genome-editing tools to treat sickle cell disease. Human Genetics 135:1011. http://dx.doi.org/10.1007/s00439-016-1688-0